Drug
Fezolinetant
Fezolinetant: highest development phase Phase 3, developed by Astellas. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Astellas
Trials
| Drug | Phase | Indication |
|---|---|---|
| fezolinetant NCT04003389 | Phase 3 | Hot Flashes |
| Fezolinetant NCT07829653 | Phase 3 | Hot Flashes |
| Fezolinetant NCT06440967 | Phase 3 | Hot Flashes |
Latest
No recent events.
Follow Fezolinetant on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.